Key statistics
As of last trade BioNexus Gene Lab Corp (BGLC:NAQ) traded at 2.03, 5.53% above its 52-week low of 1.92, set on Feb 10, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 2.02 |
|---|---|
| High | 2.07 |
| Low | 2.01 |
| Bid | 2.01 |
| Offer | 2.09 |
| Previous close | 1.95 |
| Average volume | 52.70k |
|---|---|
| Shares outstanding | 2.36m |
| Free float | 1.50m |
| P/E (TTM) | -- |
| Market cap | 4.61m USD |
| EPS (TTM) | -1.28 USD |
Data delayed at least 15 minutes, as of Feb 12 2026 16:58 GMT.
More ▼
- BioNexus Launches Regional Deployment of VitaGuard™ MRD Infrastructure; Positioned to Challenge Legacy Oncology Platforms Across ASEAN’s Multi-Billion Dollar Market
- BioNexus Gene Lab Corp. Completes Strategic Investment in Fidelion Diagnostics; Secures 15% Equity Stake in Global AI-Oncology Platform and Exclusive Southeast Asian Rights for VitaGuard™
- BioNexus Gene Lab Corp. (Nasdaq: BGLC) Secures $500 Million Equity Facility From ARC Group International to Support Expansion of Precision Diagnostics, CDMO Operations, and Therapeutic Commercialization
- BioNexus Gene Lab Corp. (Nasdaq: BGLC) and Fidelion Diagnostics Execute Exclusive Southeast Asia License for VitaGuard™ MRD Platform as Part of Strategic Alliance with Tongshu Gene
- BioNexus Gene Lab Corp. (Nasdaq: BGLC) Announces Strategic Agreements with Fidelion Diagnostics for Southeast Asia MRD Commercialization
- BioNexus Gene Lab Corp. Files $100 Million Shelf Registration and Establishes $20 Million At-the-Market Program to Advance Strategic Growth Opportunities
- BioNexus Gene Lab Corp Signs Strategic Partnership Term Sheet with BirchBioMed Inc.
- BioNexus Gene Lab Corp. and Fidelion Diagnostics Announce Landmark Alliance—Touted as a new “DeepSeek Moment” in Precision Oncology
- BioNexus Gene Lab Corp. Regains Nasdaq Compliance, Signaling Strategic Stability and Growth Readiness
- BioNexus Gene Lab Corp. Files 2024 Annual Report Highlighting Strategic Innovation, Operational Resilience, and Growth Trajectory
More ▼
